| Literature DB >> 28088442 |
Yi Lu1, Jianping Qi1, Xiaochun Dong1, Weili Zhao2, Wei Wu3.
Abstract
There has been significant research interest in, and development of, nanocrystals in recent years for the delivery of poorly water-soluble drugs via various routes. However, there is a common misinterpretation of nanocrystallization as an approach to modulate, and more specifically to enhance, the dissolution of drug crystals. Nevertheless, it is possible for nanocrystals to interact with biological tissues because nanocrystals can survive for a longer duration in vivo compared with solution counterparts. Therefore, understanding the in vivo fate of nanocrystals and determining its contribution to efficacy is of tremendous significance for optimizing the performance of nanocrystals. Here, we critically review the general hypotheses related to the in vivo fate of nanocrystals.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28088442 DOI: 10.1016/j.drudis.2017.01.003
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851